Latest MissionIR Articles

MissionIRNewsBreaks – Why Turbo Energy S.A. (NASDAQ: TURB) Is ‘One to Watch’

December 01, 2023 2:26pm

Turbo Energy (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally. “Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship product, the … Continue reading

Read Article

MissionIRNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Eyes ‘Encouraging’ Results from CLEAR MIND Trial

December 01, 2023 1:28pm

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, in October announced topline results from its phase 2a CLEAR MIND trial, investigating Lomecel-B(TM) for the treatment of mild Alzheimer’s disease (“AD”). “Lomecel-B(TM) is … Continue reading

Read Article

MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) CEO Featured in BTV Release Bolivia Project

December 01, 2023 10:45am

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), a leading exploration and mine development company, will be spotlighted in an upcoming BNN Bloomberg broadcast in Canada. The broadcast features BTV-Business Television interviews and will be aired on Dec. 2, 2023, … Continue reading

Read Article

Vision Marine Technologies Inc. (NASDAQ: VMAR) Is ‘One to Watch’

December 01, 2023 8:45am

Vision Marine Technologies (NASDAQ: VMAR) is a global leader and innovator within the performance electric recreational boating industry. The company is engaged in designing and manufacturing electric outboard powertrain systems and related technology. It strives to be a guiding force … Continue reading

Read Article

Lexaria Bioscience Corp. (NASDAQ: LEXX) Building a Global Presence with Superior Delivery Technology for Wide Range of Drugs and Active Pharmaceutical Ingredients

December 01, 2023 8:00am

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains committed to its mission to provide healthier delivery methods of drugs and other Active Pharmaceutical Ingredients (“APIs”). This is made possible through its patented drug delivery technology, DehydraTECH(TM), … Continue reading

Read Article

MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Announces Completion of Continental Envelope Solar Facility

November 30, 2023 10:48am

Correlate Energy (OTCQB: CIPI), a growth-oriented distributed energy company, has completed construction of one of Illinois’ largest rooftop, solar-power facilities. The project is located at Continental Envelope’s manufacturing plant in Geneva, Illinois. A pioneering independent manufacturer of commercial envelopes since … Continue reading

Read Article

MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Closes on Public Offering Resulting in Gross Proceeds of $5M

November 30, 2023 10:29am

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, has closed on its previously announced public offering. According to the announcement, the offering was comprised of 3,846,154 shares of its common stock (or prefunded warrants in … Continue reading

Read Article

MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Maturity Extension of EIB Finance Facility

November 29, 2023 1:28pm

Scinai Immunotherapeutics (NASDAQ: SCNI) today announced the execution of a formal amendment to its finance contract with the European Investment Bank (“EIB”). According to the announcement, the amendment extends the maturity date of the contract by four years from Dec. … Continue reading

Read Article

Webcast Sheds Light on Diamond Lake Minerals Inc. (DLMI) Groundbreaking STO Strategy Amid Rapid Early Buildup

November 29, 2023 8:00am

Multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) CEO Brian J. Esposito highlighted the company’s rapid early growth trajectory during a new interview with the Proactive Investors webcast, pointing out Diamond Lake’s market capitalization jump from “around a million dollars” … Continue reading

Read Article

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Tech Lowers Blood Glucose More Effectively than Branded GLP-1 drug Semaglutide Alone, Study Shows

November 28, 2023 11:48am

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting additional positive interim results from its human pilot study evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially as Rybelsus(R). According to … Continue reading

Read Article

MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Announces Soft Bait Fertility Solution in California Ace Hardware Stores, Prices Public Offering

November 28, 2023 10:58am

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, has launched its Evolve(TM) Soft Bait product at Ace Hardware franchise locations in California; the franchise also began selling SenesTech’s Isolate(TM) bait system. According to the announcement, this … Continue reading

Read Article

SuperCom Ltd. (NASDAQ: SPCB) Marks Exceptional Performance for Q3 2023; Eyes Further Potential Margin Expansion

November 28, 2023 8:45am

SuperCom (NASDAQ: SPCB), a global leading provider of traditional and digital identity solutions offering advanced safety, identification, and security solutions to governments, just released its financial and operating results for the third quarter of the 2023 financial year (“Q3 2023”). … Continue reading

Read Article

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Improve Oral Performance of GLP-1 Drug in Human Pilot Study

November 27, 2023 2:06pm

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced positive interim results from a human pilot study currently underway evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, which is … Continue reading

Read Article

MissionIRNewsBreaks – Safety Shot (NASDAQ: SHOT) Begins Scientific Study, Hires Securities Litigation Attorney

November 27, 2023 1:16pm

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, has begun a double-blind, placebo-controlled clinical trial designed to study and evaluate the effects of its flagship product, Safety Shot, on blood and breath alcohol levels. According to the announcement, … Continue reading

Read Article

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Update on CBP Application for Class 1 EV Cargo Vans

November 27, 2023 12:45pm

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that the company and Rapid Response Defense Systems (“RRDS”) have filed responses for final ruling and compliance by the U.S. Customs and Border Protection (“CBP”) application for Mullen’s … Continue reading

Read Article

MissionIRNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Closes on Public Offering Reaching Estimated $7M

November 27, 2023 12:36pm

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has closed its previously announced public offering. The offering was comprised of 5,384,615 shares of common stock (or common stock equivalents in lieu thereof) and warrants; the … Continue reading

Read Article

D-Wave Quantum Inc. (NYSE: QBTS) Announces Third-Quarter Financial Highlights, Voices Support for Expanded National Quantum Initiative

November 27, 2023 8:45am

D-Wave Quantum (NYSE: QBTS), a leader in commercial quantum computing systems, software, and services, recently announced financial results for its fiscal third quarter, which ended September 30, 2023. D-Wave CEO Dr. Alan Baratz believes this is a pivotal moment in … Continue reading

Read Article

MissionIRNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview

November 22, 2023 3:21pm

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, was featured in a recent Proactive interview. Mark Dybul, CEO of Renovaro, joined host Steve Darling to talk … Continue reading

Read Article